探索診斷 DGX
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 173.53 | 97.97 | 19.92 | 2.18 | 386,000 | 245 |
| 2025Q3 | 190.58 | 97.97 | 22.46 | 2.16 | 386,000 | 245 |
| 2025Q2 | 179.63 | 97.12 | 22.36 | 2.47 | 438,000 | 282 |
| 2025Q1 | 169.20 | 100.87 | 20.93 | 1.94 | 346,000 | 220 |
| 2024Q4 | 150.86 | 99.18 | 19.33 | 1.95 | 361,000 | 222 |
| 2024Q3 | 155.25 | 95.65 | 20.55 | 1.99 | 330,000 | 226 |
| 2024Q2 | 136.88 | 99.16 | 17.97 | 2.03 | 355,000 | 229 |
| 2024Q1 | 133.11 | 97.09 | 17.26 | 1.72 | 300,000 | 194 |
| 2023Q4 | 137.88 | 96.39 | 20.32 | 1.70 | 267,000 | 192 |
| 2023Q3 | 121.86 | 100.88 | 17.23 | 1.96 | 342,000 | 225 |
| 2023Q2 | 140.56 | 98.31 | 19.83 | 2.05 | 348,000 | 235 |
| 2023Q1 | 141.48 | 97.76 | 16.60 | 1.78 | 305,000 | 202 |
| 2022Q4 | 156.44 | 95.74 | 14.43 | 0.92 | 135,000 | 101 |
| 2022Q3 | 122.69 | 102.08 | 9.64 | 2.17 | 392,000 | 256 |
| 2022Q2 | 132.98 | 108.08 | 10.52 | 1.96 | 388,000 | 234 |
| 2022Q1 | 136.86 | 104.91 | 8.69 | 2.92 | 513,000 | 355 |
| 2021Q4 | 173.01 | 99.44 | 10.64 | 3.14 | 536,000 | 390 |
| 2021Q3 | 145.31 | 94.22 | 8.13 | 4.03 | 652,000 | 505 |
| 2021Q2 | 131.97 | 62.34 | 7.14 | 4.92 | 533,000 | 631 |
| 2021Q1 | 128.34 | 99.40 | 9.51 | 3.46 | 660,000 | 469 |